Revenio: Springing to life
We expect the start of the year to still have been difficult for Revenio, with Q1 results below the strong comparison period, but a return to earnings growth thereafter. The valuation level is reasonable (2024e EV/EBIT 22x) relative to the outlook for the next few years, and the company is undervalued compared to its peer group. As a result, we consider the stock's risk/reward ratio to be reasonably good again.
Login required
This content is only available for logged in users
Revenio Group
Revenio is a medical technology company. Within the Group, there is research and development of pressure measurement technology that is used in the treatment of a number of diseases such as glaucoma, osteoporosis, skin cancer, and asthma. Operations are held worldwide and are run via most subsidiaries, each with a business focus. The company's head office is located in Vantaa.
Read more on company pageKey Estimate Figures04.04.
2023 | 24e | 25e | |
---|---|---|---|
Revenue | 96.6 | 104.6 | 120.1 |
growth-% | -0.45 % | 8.33 % | 14.80 % |
EBIT (adj.) | 28.5 | 30.4 | 37.9 |
EBIT-% (adj.) | 29.53 % | 29.09 % | 31.53 % |
EPS (adj.) | 0.80 | 0.88 | 1.12 |
Dividend | 0.38 | 0.42 | 0.58 |
Dividend % | 1.40 % | 1.53 % | 2.12 % |
P/E (adj.) | 33.95 | 31.31 | 24.65 |
EV/EBITDA | 23.75 | 21.30 | 16.79 |
![](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90/https://keskustelut.inderes.fi/user_avatar/keskustelut.inderes.fi/penttihirvonen/500/128461_2.png)
![](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90/https://keskustelut.inderes.fi/user_avatar/keskustelut.inderes.fi/veronmaksaja/500/79821_2.png)
![](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90/https://keskustelut.inderes.fi/user_avatar/keskustelut.inderes.fi/ruukie/500/96208_2.png)
![](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90/https://keskustelut.inderes.fi/user_avatar/keskustelut.inderes.fi/sheikki/500/132659_2.png)
![](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90/https://keskustelut.inderes.fi/letter_avatar_proxy/v4/letter/j/c5a1d2/500.png)
![](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90/https://keskustelut.inderes.fi/user_avatar/keskustelut.inderes.fi/penttihirvonen/500/128461_2.png)